Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 3480637, 12 pages
http://dx.doi.org/10.1155/2016/3480637
Research Article

Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice

1Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, Orbassano, 10043 Torino, Italy
2Department of Drug Science and Technology, University of Turin, Corso Raffaello 33, 10125 Torino, Italy
3Department of Life Sciences and Systems Biology, University of Torino, via Accademia Albertina 13, 10123 Torino, Italy
4National Institute for Cardiovascular Research, via Irnerio 48, 40126 Bologna, Italy

Received 23 July 2015; Accepted 9 September 2015

Academic Editor: Andrés Trostchansky

Copyright © 2016 Raffaella Mastrocola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Pulakat, V. G. DeMarco, S. Ardhanari et al., “Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 301, no. 4, pp. R885–R895, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. G. D. Thakker, N. G. Frangogiannis, P. T. Zymek et al., “Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity,” Obesity, vol. 16, no. 12, pp. 2593–2600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Wensley, K. Salaveria, A. C. Bulmer, D. G. Donner, and E. F. Du Toit, “Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance,” Experimental Physiology, vol. 98, no. 11, pp. 1552–1564, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley, “Myocardial fatty acid metabolism in health and disease,” Physiological Reviews, vol. 90, no. 1, pp. 207–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Vandanmagsar, Y.-H. Youm, A. Ravussin et al., “The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance,” Nature Medicine, vol. 17, no. 2, pp. 179–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Collino, E. Benetti, M. Rogazzo et al., “Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation,” Biochemical Pharmacology, vol. 85, no. 2, pp. 257–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Mezzaroma, S. Toldo, D. Farkas et al., “The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 49, pp. 19725–19730, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Wanderer, “Ischemic-reperfusion syndromes: biochemical and immunologic rationale for IL-1 targeted therapy,” Clinical Immunology, vol. 128, no. 2, pp. 127–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. J. Tack, R. Stienstra, L. A. B. Joosten, and M. G. Netea, “Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family,” Immunological Reviews, vol. 249, no. 1, pp. 239–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kawaguchi, M. Takahashi, T. Hata et al., “Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury,” Circulation, vol. 123, no. 6, pp. 594–604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Fuentes-Antrás, A. M. Ioan, J. Tuñón, J. Egido, and Ó. Lorenzo, “Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation,” International Journal of Endocrinology, vol. 2014, Article ID 847827, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp, “Thioredoxin-interacting protein links oxidative stress to inflammasome activation,” Nature Immunology, vol. 11, no. 2, pp. 136–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Aragno, R. Mastrocola, C. Ghé et al., “Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms,” Cardiovascular Diabetology, vol. 11, article 129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Pagliaro, F. Moro, F. Tullio, M.-G. Perrelli, and C. Penna, “Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling,” Antioxidants and Redox Signaling, vol. 14, no. 5, pp. 833–850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Hausenloy and D. M. Yellon, “New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway,” Cardiovascular Research, vol. 61, no. 3, pp. 448–460, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Ferdinandy, D. J. Hausenloy, G. Heusch, G. F. Baxter, and R. Schulz, “Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning,” Pharmacological Reviews, vol. 66, no. 4, pp. 1142–1174, 2014. View at Publisher · View at Google Scholar
  17. J. Hyvärinen, I. E. Hassinen, R. Sormunen et al., “Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury,” The Journal of Biological Chemistry, vol. 285, no. 18, pp. 13646–13657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Jürgensen, C. Rosenberger, M. S. Wiesener et al., “Persistent induction of HIF-1α and -2α in cardiomyocytes and stromal cells of ischemic myocardium,” The FASEB Journal, vol. 18, no. 12, pp. 1415–1417, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. B. Pampín, S. A. García Rivero, X. L. Otero Cepeda, A. V. Boquete, J. F. Vila, and R. H. Fonseca, “Immunohistochemical expression of HIF-1α in response to early myocardial ischemia,” Journal of Forensic Sciences, vol. 51, no. 1, pp. 120–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. H. Lee, P. L. Wolf, R. Escudero, R. Deutsch, S. W. Jamieson, and P. A. Thistlethwaite, “Early expression of angiogenesis factors in acute myocardial ischemia and infarction,” The New England Journal of Medicine, vol. 342, no. 9, pp. 626–633, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Wu, P. Chen, Y. Li et al., “HIF-1α in heart: protective mechanisms,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 6, pp. H821–H828, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. B. Rankin, J. Rha, M. A. Selak et al., “Hypoxia-inducible factor 2 regulates hepatic lipid metabolism,” Molecular and Cellular Biology, vol. 29, no. 16, pp. 4527–4538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Penna, M. Brancaccio, F. Tullio et al., “Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury,” Basic Research in Cardiology, vol. 109, article 418, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Aragno, R. Mastrocola, C. Medana et al., “Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes,” Endocrinology, vol. 147, no. 12, pp. 5967–5974, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Rajesh, S. Bátkai, M. Kechrid et al., “Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy,” Diabetes, vol. 61, no. 3, pp. 716–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. E. Schaffer, “Lipotoxicity: when tissues overeat,” Current Opinion in Lipidology, vol. 14, no. 3, pp. 281–287, 2003. View at Publisher · View at Google Scholar
  27. R. Salie, B. Huisamen, and A. Lochner, “High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury,” Cardiovascular Diabetology, vol. 13, article 109, 2014. View at Publisher · View at Google Scholar
  28. Y. Xu, L.-L. Ma, C. Zhou et al., “Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection,” PLoS ONE, vol. 8, no. 10, Article ID e76652, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. D. J. Hausenloy and D. M. Yellon, “Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection,” Heart Failure Reviews, vol. 12, no. 3-4, pp. 217–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Ghaboura, S. Tamareille, P.-H. Ducluzeau et al., “Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling,” Basic Research in Cardiology, vol. 106, no. 1, pp. 147–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Collino, E. Benetti, M. Rogazzo et al., “A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice,” British Journal of Pharmacology, vol. 171, no. 24, pp. 5802–5815, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. L.-L. Ma, F.-J. Zhang, L.-B. Qian et al., “Hypercholesterolemia blocked sevoflurane-induced cardioprotection against ischemia-reperfusion injury by alteration of the MG53/RISK/GSK3β signaling,” International Journal of Cardiology, vol. 168, no. 4, pp. 3671–3678, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Kojima, T. Tanaka, R. Inagi et al., “Protective role of hypoxia-inducible factor-2α against ischemic damage and oxidative stress in the kidney,” Journal of the American Society of Nephrology, vol. 18, no. 4, pp. 1218–1226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-G. Ong and D. J. Hausenloy, “Hypoxia-inducible factor as a therapeutic target for cardioprotection,” Pharmacology and Therapeutics, vol. 136, no. 1, pp. 69–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. C. M. Taniguchi, E. C. Finger, A. J. Krieg et al., “Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes,” Nature Medicine, vol. 19, no. 10, pp. 1325–1330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Wei, S. M. Piecewicz, L. M. McGinnis et al., “A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition,” Nature Medicine, vol. 19, no. 10, pp. 1331–1337, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Benetti, F. Chiazza, N. S. A. Patel, and M. Collino, “The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders,” Mediators of Inflammation, vol. 2013, Article ID 678627, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Toldo, E. Mezzaroma, A. G. Mauro, F. Salloum, B. W. Van Tassell, and A. Abbate, “The inflammasome in myocardial injury and cardiac remodeling,” Antioxidants & Redox Signaling, vol. 22, no. 13, pp. 1146–1161, 2015. View at Publisher · View at Google Scholar
  39. G. H. Goossens, E. E. Blaak, R. Theunissen et al., “Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans,” Molecular Immunology, vol. 50, no. 3, pp. 142–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. H.-M. Lee, J.-J. Kim, H. J. Kim, M. Shong, B. J. Ku, and E.-K. Jo, “Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes,” Diabetes, vol. 62, no. 1, pp. 194–204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Liu, K. Lian, L. Zhang et al., “TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury,” Basic Research in Cardiology, vol. 109, no. 5, article 415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Marchetti, J. Chojnacki, S. Toldo et al., “A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse,” Journal of Cardiovascular Pharmacology, vol. 63, no. 4, pp. 316–322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Scortegagna, K. Ding, Y. Oktay et al., “Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice,” Nature Genetics, vol. 35, no. 4, pp. 331–340, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Chen, R. Na, E. Boldt, and Q. Ran, “NLRP3 inflammasome activation by mitochondrial reactive oxygen species plays a key role in long-term cognitive impairment induced by paraquat exposure,” Neurobiology of Aging, vol. 36, no. 9, pp. 2533–2543, 2015. View at Publisher · View at Google Scholar
  45. F. Usui, K. Shirasuna, H. Kimura et al., “Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 1, pp. 127–136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Zhuang, M. Yasinta, C. Hu et al., “Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury,” The American Journal of Physiology—Renal Physiology, vol. 308, no. 8, pp. F857–F866, 2015. View at Publisher · View at Google Scholar
  47. A. Kauppinen, H. Niskanen, T. Suuronen, K. Kinnunen, A. Salminen, and K. Kaarniranta, “Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD),” Immunology Letters, vol. 147, no. 1-2, pp. 29–33, 2012. View at Publisher · View at Google Scholar · View at Scopus